Significant treatment failure with intravitreous bevacizumab for retinopathy of prematurity. [electronic resource]
Producer: 20120927Description: 801-2 p. digitalISSN:- 1538-3601
- Angiogenesis Inhibitors -- administration & dosage
- Antibodies, Monoclonal, Humanized -- administration & dosage
- Bevacizumab
- Disease Progression
- Gestational Age
- Humans
- Infant, Extremely Low Birth Weight
- Infant, Newborn
- Intravitreal Injections
- Recurrence
- Retinal Detachment -- diagnostic imaging
- Retinopathy of Prematurity -- drug therapy
- Treatment Failure
- Ultrasonography
- Vascular Endothelial Growth Factor A -- antagonists & inhibitors
No physical items for this record
Publication Type: Case Reports; Letter
There are no comments on this title.
Log in to your account to post a comment.